Latest Breaking News On - Neuroscience stock down - Page 1 : comparemela.com

Q1 2025 Earnings Estimate for Vigil Neuroscience, Inc (NASDAQ:VIGL) Issued By Wedbush

Q1 2025 Earnings Estimate for Vigil Neuroscience, Inc (NASDAQ:VIGL) Issued By Wedbush
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionVigil neuroscience incVigil neuroscience company profileVigil neuroscienceFree reportGet free reportNeuroscience stock downVigil neuroscience daily

Vigil Neuroscience (NASDAQ:VIGL) Rating Reiterated by Wedbush

Wedbush reiterated their outperform rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) in a report published on Friday, Benzinga reports. Wedbush currently has a $23.00 price objective on the stock. Several other equities analysts have also recently commented on VIGL. JMP Securities began coverage on shares of Vigil Neuroscience in a research report […]

Vigil neuroscience incVigil neuroscience company profileTrustees of columbia universityVanguard group incBlackrock incVigil neuroscienceFree reportModerate buyNeuroscience stock downSprings capital managementStreet corpColumbia universityNew yorkGet free reportVigil neuroscience dailyNasdaq vigl

Vigil Neuroscience (NASDAQ:VIGL) Rating Reiterated by Wedbush

Wedbush reaffirmed their outperform rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) in a research report released on Wednesday, Benzinga reports. Wedbush currently has a $23.00 target price on the stock. Wedbush also issued estimates for Vigil Neuroscience’s Q4 2023 earnings at ($0.53) EPS, FY2023 earnings at ($2.10) EPS, Q1 2024 earnings at […]

United statesVigil neuroscience incRoyal bankCitadel advisorsWells fargo companyVigil neuroscience company profileVigil neuroscienceFree reportModerate buyNeuroscience stock downState teachers retirement systemState street corpStreet corpGet free reportVigil neuroscience dailyNasdaq vigl

Vigil Neuroscience (NASDAQ:VIGL) Earns Outperform Rating from Wedbush

Wedbush reissued their outperform rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Free Report) in a report released on Wednesday, Benzinga reports. Wedbush currently has a $23.00 target price on the stock. Wedbush also issued estimates for Vigil Neuroscience’s Q4 2023 earnings at ($0.53) EPS, FY2023 earnings at ($2.10) EPS, Q1 2024 earnings at ($0.48) […]

Vigil neuroscience company profileGeode capital managementVigil neuroscience incBlackrock incCitadel advisorsVanguard group incVigil neuroscienceFree reportModerate buyNeuroscience stock downGet free reportSprings capital managementCapital managementVigil neuroscience dailyNasdaq viglReiterated rating

Reunion Neuroscience (NASDAQ:REUN) Now Covered by Analysts at ThinkEquity

ThinkEquity assumed coverage on shares of Reunion Neuroscience (NASDAQ:REUN – Get Rating) in a research note published on Monday morning, The Fly reports. The brokerage issued a buy rating on the stock. A number of other brokerages have also recently commented on REUN. Stifel Nicolaus cut Reunion Neuroscience from a buy rating to a hold […]

United statesStifel nicolausField trip health centresReunion neuroscience company profileField trip health ltdReunion neuroscience incEf hutton acquisition coReunion neuroscienceGet ratingModerate buyNeuroscience stock downStreet groupCtrip healthField trip digitalField trip discoveryReunion neuroscience daily